News
-
-
PRESS RELEASE
EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. – dissolution becoming effective on 18 November 2024 and suspension of trading on 19 November 2024
European Healthcare Acquisition & Growth Company B.V. announces dissolution effective 18 November 2024 and trading suspension on 19 November 2024. Delisting of Public Shares to follow -
-
PRESS RELEASE
European Healthcare Acquisition & Growth Company B.V. convenes its annual general meeting of shareholders and publishes the agenda thereof
European Healthcare Acquisition & Growth Company B.V. convenes its annual general meeting of shareholders and publishes agenda. Shareholders can attend via webcast and vote electronically. Important agenda items include financial statements adoption and discharge of directors' liability -
-
PRESS RELEASE
EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. announces change in CEO position
European Healthcare Acquisition & Growth Company B.V. announces change in CEO position. Dr. Thomas Rudolph appointed as new CEO and compliance officer following Dr. Cornelius H. Baur's resignation -
-
-
-